Yellow nail syndrome is a complex, potentially painful disorder. In this article, learn about the potential causes and risk factors. […]

Research suggests that selective-serotonin reuptake inhibitors - a common class of antidepressants - could lead to the exacerbation of tinnitus. […]

For some kinds of blood tests, the patient may be required to fast beforehand. In this article, learn about fasting for blood tests. […]

A study using data from more than 77,000 participants looks at the links between long-term vitamin B supplementation and lung cancer risk. […]

(Reuters) - Weak patient admissions that plagued U.S. hospital operators in the June quarter are likely to persist through 2018, as patients fret about soaring out-of-pocket costs and the future of Obamacare remains uncertain. […]

NEW YORK (Reuters) - A massive California verdict in a lawsuit alleging Johnson & Johnson's talc-based products cause cancer has opened a new front in the litigation, upending the company's hopes that the cases were only gaining traction in Missouri, legal experts said. […]

(Reuters) - Eye doctors who had braced themselves for at least a few patients after a dazzling solar eclipse swept the United States cautiously exhaled on Tuesday, with some hospitals reporting zero cases of damaged vision so far. […]

(Reuters Health) - People who decide to tackle their cancer using only unconventional methods are likely to die sooner than patients who opt for conventional treatments, according to a new study. […]

GI Dynamics (ASX:GID) CEO Scott Schorer has had an uphill battle over the past year. His company has faced regulatory and compliance issues, negative shareholder sentiment and a number of other concerns. But Schorer and his team are committed to righting the ship and saving a product they see as having no equal in the current […] The post GI Dynamic’s Schore […]

Ventripoint Diagnostics this week announced the publication of a study of its VMS heart analysis system, touting that the system’s functionality. The study, undertaken by the cardiology group at London’s Royal Free Hospital, was published in the journal Echocardiography. Results from the study indicate that the system was able to follow patients with enlarge […]

Ultrasound device developer Verasonics said today that as part of a binding arbitration decision in a trade secret dispute, Alpinion Medical Systems has been prohibited from marketing or selling its E-Cube 12R ultrasound system for 5 years. The decision, which also came with a final award of more than $5.6 million, was confirmed last week by […] The post Alp […]

Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in […] The post MassDevice.com +5 | The top 5 […]

...s employees worldwide are building upon the company's rich heritage of medical breakthroughs to advance the next generation of healthcare innovations that enable patient care. Baxter is a registered trademark of Baxter International Inc. 1 American Society for Parenteral and ... […]

...s employees worldwide are building upon the company's rich heritage of medical breakthroughs to advance the next generation of healthcare innovations that enable patient care. View source version on businesswire.com: http://www.businesswire.com/news/home/20170821005745/en/ [ Back ... […]

...that can be commercialized through the Innovation Lab. The Innovation Lab also works in alliance with Cleveland Clinic Innovations, Global Healthcare Innovations Alliance, California Institute of Technology, and Society of Physician Entrepreneurs (SoPE). Click to Tweet About Xerox Xerox Corporation is ... […]

...complete this significant round of financing with experienced private investors who have a firm commitment to advancing these urgently needed healthcare innovations in Alzheimer's disease and other types of dementia," said Carlo Medici, CEO of Alzeca. Until now, the accuracy ... […]